Standards for the management of sickle cell disease in children

Archives of Disease in Childhood: Education and Practice Edition

Volumn 93, Issue 6, 2008, Pages 169-176

  Dick, Moira C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIMALARIAL AGENT; HEPATITIS B VACCINE; HYDROXYUREA; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE;

ACUTE CHEST SYNDROME; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER RISK; CHILD CARE; CLINICAL TRIAL; HEALTH PROGRAM; HUMAN; LEUKEMIA; MEDICAL PRACTICE; MORBIDITY; MORTALITY; NEUTROPHIL COUNT; NEWBORN SCREENING; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEPSIS; SICKLE CELL ANEMIA; SIDE EFFECT; SPIROMETRY; STREPTOCOCCUS INFECTION; VIRUS INFECTION;

ANEMIA, SICKLE CELL; BENCHMARKING; CHILD; HUMANS; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC;

EID: 57149112172     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2007.116699     Document Type: Review

References (37)

1. NHS. Sickle Cell & Thalassaemia Screening Programme. See http://www.sickleandthal.org.uk/AimsObject.htm#ProgStandards (accessed 14 October 2008).
2. Davis H, Gergen PJ, Moore RM Jr. Geographic differences in mortality of young children with sickle cell disease in the United States. Public Health Rep 1997;112:52-8.
3. NHS. UK Newborn Screening Programme Centre. UK standards. See http://www.newbornscreening-bloodspot.org.uk/ (accessed 14 October 2008).
4. NHS. Sickle cell disease in childhood - standards and guidelines for clinical care. See http://www.sickleandthal.org.uk/publications. htm#ClinicalCareGuidelines (accessed 14 October 2008).
5. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anaemia. N Engl J Med 1986;314:1593-9.
6. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
7. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
8. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell disease. N Engl J Med 1995;333:699-703.
9. Elliott V, Morgan S, Day S, et al. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. J Pediatr Hematol Oncol 2001;23:112-16.
10. Teach SJ, Lillis KA, Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med 1998;152:274-8.
11. Davies JM, Barnes R, Milligan D, et al. Update of guidelines for the prevention and treatment of infection in patients with absent or dysfunctional spleen. CM Med 2002;2:440-3.
12. Falletta JM, Woods GM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anaemia. Prophylactic Penicillin Study II. J Pediatr 1995;127:685-90.
13. Gill FM, Brown A, Gallagher D, et al. Newborn experience in the Cooperative Study of Sickle Cell Disease. Pediatrics 1989;83:827-9.
14. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-63.
15. Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised child. Best practice statement. London: RCPCH, 2002. Available from www.rcpch.ac.uk/publications/ (accessed 14 October 2008).
16. Department of Health. Planned changes to the routine Child Immunisation Programme. London: OH, 2006. Available from www.dh.gov.uk/assetRoot/04/12/81/21/04128121.pdf (accessed 14 October 2008).
17. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 2003;143:438-44.
18. Pegelow CH, Macklin EA, Moser FG. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease, Blood 2002;99:3014-21.
19. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-10.
20. Intercollegiate Working Party for Paediatric Stroke. Clinical guidelines for the diagnosis and management of acute stroke in childhood. London: Royal College of Physicians, 2004.
21. DeBaun MR, Schatz J, Siegel MU, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 1998;50:1678-82.
22. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarct as a risk factor for overt stroke in children with sickle cell anaemia: a report from the Cooperative Study of Sickle Cell. J Pediatr 2001;139:385- 90.
23. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-9.
24. Cohen AR, Martin MB, Silber JH, et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-61.
25. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anaemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-52.
26. NHS. A parent's guide - care and management of your child with sickle cell disease (June 2007). Available from http://www.sickleandthal.org.uk/ publications.htm (accessed 14 October 2008).
27. Rees DC, Olujohungbe AD, Parker NE, et al. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120:744-52.
28. Dick M. Management of sickle disease in childhood. In: Okpala I, ed. Practical management of haemoglobinopathies. Oxford: Blackwell, 2004:76-87.
29. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
30. Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996;88:1960-4.
31. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anaemia: risks and benefits of up to 9 years of treatment. JAMA 2003;289:1645-51.
32. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001;139:790-6.
33. Hankins JS, Ware RE, Rogers ZR, et al. Long term hydroxyurea therapy for infants with sickle cell anaemia: the HUSOFT extension study. Blood 2005;106:2269-75.
34. Davies SC, Roberts JA. Bone marrow transplant for sickle cell disease - an update. Arch Dis Child 1996;75:3-6.
35. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997;89:1787-92.
36. Chen E, Cole SW, Kato PM. A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol 2004;29:197-209.
37. NCEPOD. Sickle: A sickle crisis? See http.//www.ncepod.org.uk/ 2008report1/Downloads/Sickle_report.pdf (accessed 14 October 2008).